Missouri Valley Cancer Consortium CCOP

密苏里河谷癌症联盟 CCOP

• 批准号: 6478025
• 负责人: JAMES A MAILLIARD
• 金额: $ 98万
• 依托单位: CANCER ALLIANCE OF NEBRASKA
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-09-30 至 2007-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6478025
• 关键词: antineoplastic antibiotics; antineoplastics; behavioral /social science research tag; biliary tract neoplasm; blood /lymphatic neoplasm; bone neoplasms; brain neoplasms; breast neoplasms; cancer complication; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; ceramides; chemoprevention; clinical research; colony stimulating factor; community health services; cooperative study; data management; esophagus neoplasm; estrogens; female reproductive system neoplasm; gastrointestinal neoplasms; head /neck neoplasm; health services research tag; hormone therapy; human subject; human therapy evaluation; inhalation drug administration; interferons; interleukin 2; lung neoplasms; medical outreach /case finding; medical rehabilitation related tag; melanoma; neoplasm /cancer chemotherapy; neoplasm /cancer education; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer palliative treatment; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; neoplasm /cancer therapy; pancreas neoplasms; patient oriented research; prostate neoplasms; selenium; tocopherols; topical drug application

DESCRIPTION (provided by applicant): The Missouri Valley Cancer Consortium (MVCC) is a community-based research effort with the specific aim of providing quality cancer care and research opportunities to patients in their respective communities. This is accomplished primarily through a networking of physicians, hospitals, and community cancer clinics across Nebraska and Iowa who recognize the unique needs of people with cancer, and who are committed to providing cancer care that has an emphasis on research whereby patients may benefit from cutting-edge technology in the areas of cancer treatment, cancer control, and cancer prevention. The MVCC serves a catchment area of primarily Nebraska and Iowa, and through affiliation with nationally recognized research groups, clinical trials are offered for a wide variety of cancers. A unique ability to provide clinical trials for cancer prevention and cancer control enhances the quality of this vital research program. The MVCC has direct affiliation with the North Central Cancer Treatment Group, Eastern Cooperative Oncology Group, Radiation Therapy Oncology Group, National Surgical Adjuvant Breast and Bowel Project, Gynecologic Oncology Group, and Southwest Oncology Group, is a member of the CTSU, or Clinical Trials Support Unit of the NIH, receives funding to support the program through an NIH grant as a Community Clinical Oncology Program (CCOP), and serves a data base of well over 1800 patients who have enrolled in clinical research studies over the years through their own community medical programs affiliated with MVCC. The MVCC has a proven track record of producing quality research work from a deeply committed team of healthcare professionals. Efforts are now being focused on community awareness of the importance of clinical research participation through pathways of public education about cancer, along with cancer screening and cancer prevention programs. Strategies to include minority populations in these important programs are being utilized as well. The long-term objective of this vital research program is to provide cancer patients access to clinical trials in their community, to promote quality cancer care and education, and to produce research data that will ultimately benefit all cancer patients.

描述（由申请人提供）：密苏里河谷癌症联盟 (MVCC) 是一项基于社区的研究工作，其具体目标是提供 为各自领域的患者提供优质的癌症护理和研究机会 社区。这主要是通过网络来完成的 内布拉斯加州和爱荷华州的医生、医院和社区癌症诊所 他们认识到癌症患者的独特需求，并致力于 提供以研究为重点的癌症护理，使患者可以 受益于癌症治疗、癌症领域的尖端技术 控制和癌症预防。 MVCC 的服务范围主要为 内布拉斯加州和爱荷华州，并通过与国家认可的研究机构的联系 小组针对多种癌症提供了临床试验。一个独特的 提供癌症预防和控制临床试验的能力 提高这一重要研究计划的质量。 MVCC 有直接 与东部合作社中北癌症治疗组的隶属关系 肿瘤学组、放射治疗肿瘤学组、国家手术辅助组 乳腺和肠道项目、妇科肿瘤学组和西南肿瘤学 集团是 CTSU（NIH 临床试验支持单位）的成员， 作为社区通过 NIH 拨款获得资金支持该计划 临床肿瘤学计划 (CCOP)，并提供超过 1800 个数据库 多年来参加临床研究的患者 他们自己的社区医疗计划隶属于 MVCC。 MVCC 有一个 有着坚定的承诺，提供高质量研究工作的良好记录 医疗保健专业人员团队。现在的努力主要集中在社区 通过以下方式认识到参与临床研究的重要性 关于癌症的公共教育途径以及癌症筛查和 癌症预防计划。将少数民族人口纳入其中的战略 这些重要的计划也正在得到利用。长期目标 这项重要研究计划的目的是为癌症患者提供 在他们的社区进行临床试验，以促进优质的癌症护理和 教育，并产生最终惠及所有人的研究数据 癌症患者。